1. Home
  2. ARCT vs BIOX Comparison

ARCT vs BIOX Comparison

Compare ARCT & BIOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • BIOX
  • Stock Information
  • Founded
  • ARCT 2013
  • BIOX 2001
  • Country
  • ARCT United States
  • BIOX Argentina
  • Employees
  • ARCT N/A
  • BIOX N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • BIOX Agricultural Chemicals
  • Sector
  • ARCT Health Care
  • BIOX Industrials
  • Exchange
  • ARCT Nasdaq
  • BIOX Nasdaq
  • Market Cap
  • ARCT 298.3M
  • BIOX 275.1M
  • IPO Year
  • ARCT N/A
  • BIOX N/A
  • Fundamental
  • Price
  • ARCT $11.86
  • BIOX $4.68
  • Analyst Decision
  • ARCT Strong Buy
  • BIOX Strong Buy
  • Analyst Count
  • ARCT 7
  • BIOX 4
  • Target Price
  • ARCT $57.40
  • BIOX $8.63
  • AVG Volume (30 Days)
  • ARCT 410.5K
  • BIOX 107.1K
  • Earning Date
  • ARCT 05-12-2025
  • BIOX 05-20-2025
  • Dividend Yield
  • ARCT N/A
  • BIOX N/A
  • EPS Growth
  • ARCT N/A
  • BIOX N/A
  • EPS
  • ARCT N/A
  • BIOX 0.02
  • Revenue
  • ARCT $143,680,000.00
  • BIOX $407,732,105.00
  • Revenue This Year
  • ARCT N/A
  • BIOX N/A
  • Revenue Next Year
  • ARCT $44.93
  • BIOX $7.55
  • P/E Ratio
  • ARCT N/A
  • BIOX $196.93
  • Revenue Growth
  • ARCT 15.38
  • BIOX N/A
  • 52 Week Low
  • ARCT $8.04
  • BIOX $3.51
  • 52 Week High
  • ARCT $45.00
  • BIOX $13.18
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 50.74
  • BIOX 57.54
  • Support Level
  • ARCT $10.70
  • BIOX $4.38
  • Resistance Level
  • ARCT $13.10
  • BIOX $4.85
  • Average True Range (ATR)
  • ARCT 0.89
  • BIOX 0.32
  • MACD
  • ARCT -0.01
  • BIOX 0.06
  • Stochastic Oscillator
  • ARCT 35.69
  • BIOX 80.00

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

About BIOX Bioceres Crop Solutions Corp.

Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

Share on Social Networks: